Market Overview

Benzinga's Top Pre-Market Losers

Related GILD
Morningstar: Gilead Sciences To Grow Its Hepatitis C Market
These Companies Probably Won't Be Acquiring Ariad Pharmaceuticals
How To Invest In ETFs: Tips To Trade Top Market Trends (Investor's Business Daily)
Related CROX
3 Management Changes You May Have Missed This Week
UPDATE: Crocs Posts Q4 Loss, Shares Tumble
Crocs Should Have A Brighter Future (GuruFocus)

Gilead Sciences (NASDAQ: GILD) dipped 2.40% to $58.66 in the pre-market session. Gilead Sciences shares have jumped 124.40% over the past 52 weeks, while the S&P 500 index has gained 25.09% in the same period.

Crocs (NASDAQ: CROX) shares fell 2.09% to $16.40 in the pre-market trading after Wedbush downgraded the stock from “outperform” to “neutral.”

Broadcom (NASDAQ: BRCM) shares dropped 1.45% to $33.20 in pre-market trading. Broadcom's trailing-twelve-month ROA is 4.58%.

Honeywell International (NYSE: HON) dipped 0.49% to $83.16 in the pre-market session after Nomura downgraded the stock from “buy” to “neutral.”

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets


Related Articles (BRCM + CROX)

Around the Web, We're Loving...

Get Benzinga's Newsletters